×
Back to Agenda
More Nuanced Clinical Outcomes from Person-Generated Health Data: The New Frontier
Session Chair(s)
Nancy Dreyer, MPH, FISPE
Founder, Dreyer Strategies LLC, United States
Person-generated data offers nuanced effectiveness measures for clinical and regulatory decision-making for new medical products, like the wearable-derived digital clinical outcome assessment for Duchenne muscular dystrophy. What's next?
Learning Objective : Describe practical applications of person-generated health data, and key business and regulatory perspectives on opportunities and challenges; Explain the value of this type of information to patients, clinicians, and colleagues to help inform decision-making.
Speaker(s)
Christina Mack, MPH
CSO RWE and SVP AAIS, IQVIA, United States
Panelist
Jeffrey Nahum Siegel, DrMed, MD
Director, Office of Drug Evaluation Sciences, OND, CDER, FDA, United States
Panelist
Martha Azer, PHARMD, RPH
Associate Director, Global Regulatory Policy & Intelligence , Johnson & Johnson, United States
Panelist
Have an account?